Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Shares Issued: 2014-2024

Historic Shares Issued for Cidara Therapeutics (CDTX) over the last 11 years, with Dec 2024 value amounting to $337.3 million.

  • Cidara Therapeutics' Shares Issued rose 1517.76% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.9 million, marking a year-over-year increase of 142631.43%. This contributed to the annual value of $337.3 million for FY2024, which is 276400.00% up from last year.
  • Per Cidara Therapeutics' latest filing, its Shares Issued stood at $337.3 million for FY2024, which was up 276,400.00% from $122,000 recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Shares Issued ranged from a high of $337.3 million in FY2024 and a low of $122,000 during FY2023.
  • For the 3-year period, Cidara Therapeutics' Shares Issued averaged around $112.5 million, with its median value being $140,000 (2022).
  • In the last 5 years, Cidara Therapeutics' Shares Issued crashed by 98.88% in 2022 and then soared by 276,400.00% in 2024.
  • Over the past 5 years, Cidara Therapeutics' Shares Issued (Yearly) stood at $11.0 million in 2020, then rose by 13.06% to $12.5 million in 2021, then slumped by 98.88% to $140,000 in 2022, then dropped by 12.86% to $122,000 in 2023, then surged by 276,400.00% to $337.3 million in 2024.